Compounds > medroxyprogesterone
Page last updated: 2024-08-21

medroxyprogesterone and Meningioma

medroxyprogesterone has been researched along with Meningioma in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19905 (83.33)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Altinoz, MA; Del Maestro, RF; Elmaci, I; Emin Ozcan, M; Nalbantoglu, J; Ozpinar, A1
Ghatak, NR; Oppenheimer, JH; Stock, JM1
Markwalder, TM; Waelti, ER1
Haltia, M; Jääskeläinen, J; Kärkkäinen, J; Laasonen, E; Troupp, H1
König, MP; Markwalder, TM; Waelti, E1
Gerber, HA; Markwalder, RV; Markwalder, TM; Schaffner, T; Waelti, E1

Other Studies

6 other study(ies) available for medroxyprogesterone and Meningioma

ArticleYear
From epidemiology and neurodevelopment to antineoplasticity. Medroxyprogesterone reduces human glial tumor growth in vitro and C6 glioma in rat brain in vivo.
    Clinical neurology and neurosurgery, 2018, Volume: 173

    Topics: Animals; Brain; Brain Neoplasms; Cerebellar Neoplasms; Dexamethasone; Disease Models, Animal; Glioblastoma; Glioma; Humans; Medroxyprogesterone; Meningioma; Rats; Tumor Cells, Cultured

2018
Unususpected meningioma in a patient with pituitary gigantism. Case report with autopsy findings.
    Metabolism: clinical and experimental, 1975, Volume: 24, Issue:6

    Topics: Adult; Autopsy; Gigantism; Growth Hormone; Humans; Hypophysectomy; Intracranial Pressure; Male; Medroxyprogesterone; Meningioma; Radiotherapy

1975
Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on growth of primary meningioma cells in monolayer tissue culture.
    Surgical neurology, 1989, Volume: 31, Issue:2

    Topics: Antigens, Surface; Cell Division; Culture Techniques; Endocrine Glands; Humans; Immunohistochemistry; Ki-67 Antigen; Medroxyprogesterone; Medroxyprogesterone Acetate; Meningeal Neoplasms; Meningioma; Receptors, Progesterone; Tumor Cells, Cultured

1989
Hormone treatment of meningiomas: lack of response to medroxyprogesterone acetate (MPA). A pilot study of five cases.
    Acta neurochirurgica, 1986, Volume: 80, Issue:1-2

    Topics: Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Meningeal Neoplasms; Meningioma; Middle Aged; Pilot Projects; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Tomography, X-Ray Computed

1986
Endocrine manipulation of meningiomas with medroxyprogesterone acetate. Effect of MPA on receptor status of meningioma cytosols.
    Surgical neurology, 1987, Volume: 28, Issue:1

    Topics: Cytosol; Female; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Meningeal Neoplasms; Meningioma; Middle Aged; Pilot Projects; Receptors, Estrogen; Receptors, Progesterone

1987
Hormonotherapy of meningiomas with medroxyprogesterone acetate. Immunohistochemical demonstration of the effect of medroxyprogesterone acetate on growth fractions of meningioma cells using the monoclonal antibody Ki-67.
    Surgical neurology, 1988, Volume: 30, Issue:2

    Topics: Antibodies, Monoclonal; Drug Evaluation; Growth Substances; Humans; Immunoenzyme Techniques; Immunohistochemistry; Medroxyprogesterone; Medroxyprogesterone Acetate; Meningeal Neoplasms; Meningioma; Neoplasm Proteins; Peptides; Preoperative Care; Receptors, Progesterone; Reoperation; Time Factors; Transforming Growth Factors

1988